NCT03804476View on ClinicalTrials.gov

Phase 1 Study to Assess AER-271

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 26, 2018

Primary Completion Date

July 18, 2019

Study Completion Date

August 28, 2019

Conditions
StrokeStroke, AcuteStroke, Ischemic
Interventions
DRUG

AER-271

AER-271, the test article for this study.

DRUG

Placebo

Placebo control for this study.

Trial Locations (1)

75247

Covance Dallas, Dallas

Sponsors

Lead Sponsor

Aeromics, Inc.

Collaborators (1)

Covance
All Listed Sponsors
collaborator

Covance

INDUSTRY

lead

Aeromics, Inc.

INDUSTRY